Market by Component, Deployment Mode, and Country Outlook | Forecast 2023-2030
Triton’s estimates indicate that the pharmaceutical supply chain management market in Latin America is predicted to advance at a CAGR of 6.28% during the forecasted period from 2023 to 2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries evaluated in the studied region are:
•
Brazil
•
Argentina
•
Mexico
•
Rest of Latin America
The
region’s expansion can be attributed to the surge in foreign investments and
the aging population. Furthermore, restructuring the regulatory framework and
expanding trade agreements are expected to strengthen the pharmaceutical
sector. As a result, manufacturers established integrated supply chains for
healthcare products and devices to offer medical supplies at reduced costs. Hence,
numerous government and industry initiatives to promote health are helping
expand the scope and drive the growth of the pharmaceutical supply chain
management market.
Brazil is leading with the highest
share in the pharmaceutical supply chain management market. This is due to the growth of the
healthcare sector, which finds its impetus in the joint sales efforts of the
pharmaceutical companies, especially in the respiratory sector. A significant
9.1% of the country’s GDP is dedicated to supporting the expansion of the
healthcare sector. This investment underscores the country’s commitment to
healthcare and illustrates its role in promoting progress in medical services
and pharmaceuticals.
On
the other hand, Mexico is the leading importer of pharmaceuticals in Latin
America due to increased health spending and the introduction of new technologies.
These factors have significantly expanded the production and supply of
medicines, increasing the overall growth potential of the pharmaceutical supply
chain management market.
In
the current scenario, cloud-based supply chain management software solutions
have seen a remarkable rise in adoption rates. These platforms and applications
are undergoing a transformation process within supply chain management. They
effectively enhance the operational capabilities of small and complex
enterprises. Moreover, these solutions provide supply chain executives quick
and efficient access to innovative tools. This access is facilitated by a
software-as-a-service (SaaS) model, allowing it to be deployed at scale.
The market is divided into
deployment mode and component.
The deployment mode segment includes on-premise and cloud-based.
Cardinal
Health Inc, Terso Solutions Inc, Infor, SAP SE, and Manhattan Associates Inc are some of the
key companies in the given market.
Infor
provides enterprise software and services. It offers a variety of software
solutions for businesses, including cloud-based applications, customer
management, asset management, financial tools, etc. Moreover, it offers
consulting, implementation, and customer support services. Infor is headquartered
in New York City, USA, and operates in various regions, including Latin America.
Key deliverables of the report:
· Market CAGR during the forecasting
years 2023-2030
· Detailed data highlighting key
insights, industry components, and market strategies
· Comprehensive information and
estimation of the pharmaceutical supply chain management market revenue growth
in Latin America and its influence on the parent market
· In-depth study of forthcoming trends
in consumer behavioral patterns
· A meticulous analysis of the
competitive landscape, vendor scorecard, and Porter’s Five Forces
· A wide-ranging study of factors that
will challenge the LA pharmaceutical supply chain management market’s growth
during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
1. LATIN
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHT
2.2.1. EMBRACING
MODERN INVENTORY SOLUTIONS FOR DECENTRALIZED SUPPLY CHAIN
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE S
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
BUYING IMPACT ANALYSIS
2.5.1. COMPETITIVE
PRICING
2.5.2. INTEGRATION
CAPABILITIES
2.5.3. INVENTORY
MANAGEMENT
2.5.4. ANALYTICS
AND BUSINESS INTELLIGENCE
2.5.5. SECURITY
AND DATA PRIVACY
2.6. KEY
MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT
LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISING
ADOPTION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
2.7.2. IMPLEMENTATION
OF GS1 STANDARD
2.7.3. GROWING
EMPHASIS ON REDUCING HEALTHCARE EXPENDITURE
2.7.4. INCREASING
DEMAND FOR PHARMACEUTICAL PRODUCTS
2.7.5. CONCERN
REGARDING DRUG COUNTERFEITING
2.8. MARKET
CHALLENGES
2.8.1. REGULATORY
CHALLENGES IN HEALTHCARE DATA EXCHANGE
2.8.2. HIGH
COST OF SUPPLY CHAIN MANAGEMENT SOFTWARE
2.8.3. SCM
SOFTWARE ENCOUNTERS TECHNICAL ISSUES
2.8.4. PRIVACY
CONCERNS ARISING IN SCM LINKS
2.9. MARKET
OPPORTUNITIES
2.9.1. ADVANCEMENTS
IN CLINICALLY INTEGRATED SUPPLY CHAINS
2.9.2. ENHANCING
QUALITY AND CARE WITH ADVANCED SUPPLY CHAIN TECHNOLOGIES
3. LATIN
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COMPONENT
3.1. SOLUTION
3.1.1. TRANSPORTATION
MANAGEMENT SYSTEM
3.1.2. PLANNING
AND ANALYTICS
3.1.3. WAREHOUSE
AND INVENTORY MANAGEMENT SYSTEM
3.1.4. PROCUREMENT
AND SOURCING
3.1.5. MANUFACTURING
EXECUTION SYSTEM
3.2. SERVICE
3.2.1. PROFESSIONAL
SERVICES
3.2.2. MANAGED
SERVICES
4. LATIN
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY DEPLOYMENT MODE
4.1. ON-PREMISE
4.2. CLOUD-BASED
5. LATIN
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COUNTRY OUTLOOK
5.1. COUNTRY
ANALYSIS
5.1.1. BRAZIL
5.1.1.1. BRAZIL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.2. MEXICO
5.1.2.1. MEXICO
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.3. ARGENTINA
5.1.3.1. ARGENTINA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.4. REST
OF LATIN AMERICA
5.1.4.1. REST
OF LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
6. COMPETITIVE
LANDSCAPE
6.1. MCKESSON
CORPORATION
6.1.1. OVERVIEW
6.1.2. PRODUCT
PORTFOLIO
6.1.3. KEY
STRENGTHS
6.1.4. KEY
CHALLENGES
6.2. INFOR
6.2.1. OVERVIEW
6.2.2. PRODUCT
PORTFOLIO
6.2.3. KEY
STRENGTHS
6.2.4. KEY
CHALLENGES
6.3. ORACLE
CORPORATION
6.3.1. OVERVIEW
6.3.2. PRODUCT
PORTFOLIO
6.3.3. KEY
STRENGTHS
6.3.4. KEY
CHALLENGES
6.4. CARDINAL
HEALTH INC
6.4.1. OVERVIEW
6.4.2. PRODUCT
PORTFOLIO
6.4.3. KEY
STRENGTHS
6.4.4. KEY
CHALLENGES
6.5. TECSYS
INC
6.5.1. OVERVIEW
6.5.2. PRODUCT
PORTFOLIO
6.5.3. KEY
STRENGTHS
6.5.4. KEY
CHALLENGES
6.6. SAP SE
6.6.1. OVERVIEW
6.6.2. PRODUCT
PORTFOLIO
6.6.3. KEY
STRENGTHS
6.6.4. KEY
CHALLENGES
6.7. JUMP
TECHNOLOGIES INC
6.7.1. OVERVIEW
6.7.2. PRODUCT
PORTFOLIO
6.8. MANHATTAN
ASSOCIATES INC
6.8.1. OVERVIEW
6.8.2. PRODUCT
PORTFOLIO
6.8.3. KEY
STRENGTHS
6.8.4. KEY
CHALLENGES
6.9. TERSO
SOLUTIONS INC
6.9.1. OVERVIEW
6.9.2. PRODUCT
PORTFOLIO
6.9.3. KEY
STRENGTHS
6.9.4. KEY
CHALLENGES
6.10. ARVATO
GROUP
6.10.1. OVERVIEW
6.10.2. PRODUCT
PORTFOLIO
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: MAJOR FACTORS
CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 6: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $
MILLION)
TABLE 7: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $
MILLION)
TABLE 8: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $
MILLION)
TABLE 9: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030
(IN $ MILLION)
TABLE 10: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
FIGURE 1: KEY BUYING IMPACT
ANALYSIS
FIGURE 2: LATIN AMERICA PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2022 & 2030 (IN %)
FIGURE 3: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2022 & 2030 (IN
%)
FIGURE 4: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 5: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING AND ANALYTICS,
2023-2030 (IN $ MILLION)
FIGURE 6: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE AND INVENTORY
MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 7: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT AND SOURCING,
2023-2030 (IN $ MILLION)
FIGURE 8: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 9: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2022 & 2030 (IN
%)
FIGURE 10: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES,
2023-2030 (IN $ MILLION)
FIGURE 11: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2030
(IN $ MILLION)
FIGURE 12: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2022 &
2030 (IN %)
FIGURE 13: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2030 (IN $
MILLION)
FIGURE 14: LATIN AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2030 (IN $
MILLION)
FIGURE 15: LATIN AMERICA PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: BRAZIL
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: MEXICO
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: ARGENTINA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE
19: REST OF LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
2023-2030 (IN $ MILLION)